4.7 Article

Activities of Systemically Administered Echinocandins against In Vivo Mature Candida albicans Biofilms Developed in a Rat Subcutaneous Model

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 5, Pages 2365-2368

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.02288-12

Keywords

-

Funding

  1. Pfizer [WS960288]
  2. Flemish Institute for Scientific Research (FWO) [G0804.11, WO.026.11N]
  3. FWO postdoctoral fellowship
  4. KU Leuven Postdoctoral fellowship [PDMK/11/089]

Ask authors/readers for more resources

This study addresses the effects of micafungin, caspofungin, and anidulafungin against Candida albicans biofilms developed in a subcutaneous catheter rat model system. Doses of 5, 10, and 30 mg/kg (of body weight)/day (the last only for micafungin) were given intravenously for 5, 7, and 10 days. All three echinocandins caused a significant reduction of the Candida cell numbers on the implanted catheters and are thus promising for the treatment of biofilm-related infections.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available